This book provides an inclusive approach with the existing evidence concerning effectiveness, cost, and its implications on using biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of biological agents in varied autoimmune diseases. This book also offers a complete overview of the existing and futuristic biologic treatments and to draws a recommendation on how to standardize the most suitable regimen for a specific patient in the context of current guidelines.
Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics necessitates immediate investigation of individual biologic possibilities and therapeutic symptoms to best use these new treatment regimens. This handbook serves as a concise compendium to the modern therapeutic developments in the field.
It will benefit clinicians, apprentices, support staff, and healthcare professionals working in rheumatology.
Provides the rational behind use of biologics in rheumatoid diseases
Investigates the current treatment regime of existing biologics
Addresses the concerns of biologics toxicity